Literature DB >> 19246111

The influence of age and sex on disease development in a novel animal model of cardiac cachexia.

Sandra Palus1, Yoshihiro Akashi, Stephan von Haehling, Stefan D Anker, Jochen Springer.   

Abstract

UNLABELLED: Pre-clinical studies in cardiac cachexia have mostly been performed in young male rats. These models define cachexia only as a reduction in weight gain rather than weight loss. In this pilot study, we aimed to establish a model of genuine weight loss following chronic heart failure.
METHODS: Nine months old Sprague Dawley rats (10 male and 11 female) were kept under standard conditions. Weight was monitored weekly and body composition was assessed every 4 weeks over a period of 13 weeks prior to myocardial infarction (MI) surgery. After surgery, body weight was assessed twice weekly and body composition was analysed once weekly. Cardiac function was monitored before and after MI surgery.
RESULTS: Prior to MI surgery, all rats displayed stable body weight (male: 574+/-7 g, female: 294+/-6 g). Within the first week after surgery, male animals lost 43+/-9 g (p=0.001), but female rats remained weight stable (p>0.5). Lean mass (male: 399+/-2 g; female: 222+/-3 g) and fat mass (male: 99+/-1 g; female: 46+/-2 g) were stable before surgery. MI induction led to a loss of -22.5+/-5.6 g lean mass (p=0.028) and 14.7+/-3.7 g fat mass (p=0.02) in males, while females showed no significant changes (both p>0.5). Two weeks after surgery, male rats began to regain lean mass, but no change was observed for fat mass.
CONCLUSION: Adult rats display a decline in body weight after MI and are therefore a better model for studies of cardiac cachexia. This effect is only seen in male rats, while females remain weight stable. The cause of this gender effect needs further investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19246111     DOI: 10.1016/j.ijcard.2009.01.060

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.

Authors:  Andrea Bonetto; Joseph E Rupert; Rafael Barreto; Teresa A Zimmers
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

2.  Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing mice.

Authors:  Yvonne Y Clark; Loren E Wold; Laura A Szalacha; Donna O McCarthy
Journal:  Biol Res Nurs       Date:  2014-09-16       Impact factor: 2.522

3.  Increased rat neonatal activity influences adult cytokine levels and relative muscle mass.

Authors:  Bryce Buchowicz; Tiffany Yu; Dwight M Nance; Frank P Zaldivar; Dan M Cooper; Gregory R Adams
Journal:  Pediatr Res       Date:  2010-11       Impact factor: 3.756

Review 4.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Animal models of anorexia and cachexia.

Authors:  Mark Daniel Deboer
Journal:  Expert Opin Drug Discov       Date:  2009-11-01       Impact factor: 6.098

Review 6.  Muscle wasting in animal models of severe illness.

Authors:  Milan Holecek
Journal:  Int J Exp Pathol       Date:  2012-05-08       Impact factor: 1.925

7.  IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia.

Authors:  Katja Schmidt; Stephan von Haehling; Wolfram Doehner; Sandra Palus; Stefan D Anker; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-05-08       Impact factor: 12.910

8.  Role of training and detraining on inflammatory and metabolic profile in infarcted rats: influences of cardiovascular autonomic nervous system.

Authors:  Bruno Rodrigues; Aline Alves Santana; Aline Boveto Santamarina; Lila Missae Oyama; Érico Chagas Caperuto; Cláudio Teodoro de Souza; Catarina de Andrade Barboza; Leandro Yanase Rocha; Diego Figueroa; Cristiano Mostarda; Maria Cláudia Irigoyen; Fábio Santos Lira
Journal:  Mediators Inflamm       Date:  2014-06-18       Impact factor: 4.711

9.  The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats.

Authors:  Mareike S Pötsch; Anika Tschirner; Sandra Palus; Stephan von Haehling; Wolfram Doehner; John Beadle; Andrew J S Coats; Stefan D Anker; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-11-22       Impact factor: 12.910

10.  MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia.

Authors:  Mareike S Pötsch; Junichi Ishida; Sandra Palus; Anika Tschirner; Stephan von Haehling; Wolfram Doehner; Stefan D Anker; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-17       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.